See what’s clicking on FoxBusiness.com
Pharmaceutical giant Pfizer is recalling 4.2 million packages of prescription drugs because they fail to meet child safety requirements, federal safety officials said.
The recall affects Pfizer’s Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing a blister card containing eight tablets, according to a notice from the Consumer Product Safety Commission (CPSC).
The products’ packaging is not child-resistant, as required by the Packaging Prevention Act, which “poses a risk of poisoning if the contents are swallowed by young children,” the CPSC said.
DIETARY SUPPLEMENTS FOR CLAIMS THAT IT CAN CURE COVID 19: FDA
Pharmacies across the country prescribed the drug to patients between December 2021 and March 2023.
Nurtec® ODT (Rimegepant) Oral Disintegrating Tablets Blister Pack of 75mg 8 Unit Dose. (Pfizer/CPSC)
According to the Centers for Disease Control and Prevention (CDC), about 35,000 visits to the emergency room are due to accidental drug overdoses in children under the age of 5.
“The use of over-the-counter (OTC) and prescription drugs is increasing among people of all ages,” the CDC said. “Increasing drug use also increases the potential for accidental overdoses. Children are particularly vulnerable to accidental overdoses, but overdoses can be prevented.”
EYE DROPS REMINDED IF NON-STERILITY: FDA
Patients with the recently recalled prescription drug are being told to “immediately keep the recalled product out of the sight and reach of children,” the CPSC said.
| ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| PFE | PFIZER INC. | 40.28 | +0.38 | +0.95% |
They are also asked to contact Pfizer for a child resistant pouch to store the product free of charge.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
“Once the product is secured, consumers can continue to use it as instructed,” the CPSC continued.